ArticleCNS neuroscience & therapeutics2026
Sex-Specific Effects of Dexmedetomidine on Brain Microvascular Endothelial Cell Function After Traumatic Brain Injury in Juvenile Mice.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsThis study aimed to evaluate the effects of dexmedetomidine (DEX), a selective α2-adrenergic receptor agonist, on brain microvascular endothelial cell (BMEC) function and blood-brain barrier (BBB) integrity in juvenile mice following traumatic brain injury (TBI). We specifically assessed the effects of DEX on ER stress, neuroinflammation, and ferroptosis and explored potential sex-specific responses.
methodsMale and female juvenile mice were subjected to an impact-acceleration TBI model. DEX was administered during the acute phase post-injury. Muscle strength and sensorimotor coordination were measured, and BBB permeability was assessed. BMECs and cerebral microvessels were isolated from the injured and control regions for molecular analysis of inflammatory markers, ER stress activation, ferroptosis, and expression of tight junction markers.
resultsDEX treatment improved motor and coordination outcomes and reduced BBB leakage in both sexes after TBI. Molecular analyses revealed decreased inflammatory signaling, ER stress, and ferroptosis-related oxidative stress pathways in BMECs with DEX treatment. Importantly, DEX led to greater upregulation of selected tight junction markers in female mice than in male mice, suggesting possible sex-specific differences in α2-adrenergic receptor expression.
conclusionDEX provides both behavioral and cellular protection following juvenile TBI, with potential sex-dependent effects on BMECs and BBB function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.